Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
8 Results for "
CDK17
" in MedChemExpress (MCE) Product Catalog:
Products (8)
8 Results for "CDK17" in MCE Product Catalog:
Synonyms: (S,R,S)-AHPC-Me-PEG2-dabrafenib
Target:
Research Areas:
DD-03-156 ((S,R,S)-AHPC-Me-PEG2-dabrafenib) is a VHL-based PROTAC degrader targeting CDK17 and LIMK2. DD-03-156 serves as an excellent lead-like starting point for the development of selective chemical probes targeting CDK17 degradation .
Cat. No.: HY-RS02369
Target:
Research Areas:
CDK17 Human Pre-designed siRNA Set A contains three designed siRNAs for CDK17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS25295
Target:
Research Areas:
Cdk17 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cdk17 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS18806
Target:
Research Areas:
Cdk17 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cdk17 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-E70665
Target:
Research Areas:
CDK17 is highly expressed in terminally differentiated neurons, particularly those found in hippocampal regions and olfactory bulbs. CDK17/CycY Recombinant Human Active Protein Kinase is an ortholog of CDK17 .
Cat. No.: HY-E70666
Target:
Research Areas:
CDK17 is highly expressed in terminally differentiated neurons, particularly those found in hippocampal regions and olfactory bulbs. CDK17/p35NCK Recombinant Human Active Protein Kinase is an ortholog of CDK17 .
Cat. No.: HY-153718
CAS No.: 2416873-72-6
Research Areas:
KI-ARv-03 is a potent and selective ATP-competitive CDK9 inhibitor with an IC₅₀ of 0.15 μM (at 45 μM ATP), exhibiting over 130-fold selectivity against other CDKs (including CDK1-7). KI-ARv-03 reduces androgen receptor (AR)-driven transcription and proliferation in prostate cancer cells. KI-ARv-03 can be used for leukemia, pancreatic cancer, alveolar rhabdomyosarcoma (ARMS) and castration-resistant prostate cancer (CRPC) research. KI-ARv-03 is a ligand for target protein for PROTAC. KI-ARv-03 can be used to synthesize PROTAC KI-CDK9d-32 (HY-173523) [1][2].
Cat. No.: HY-P702697
Purity: ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: CDK17; PCTAIRE-Motif Protein Kinase 2; Prev. PCTK2; Protein Kinase Cdc2-Related PCTAIRE-2; PCTAIRE2; PCTAIRE Protein Kinase 2; Serine/Threonine-Protein Kinase PCTAIRE-2; Cyclin-Dependent Kinase; Cell Division Protein Kinase 17; Cyclin Dependent Kinase 17
Species:
Human
Source:
Sf9 insect cells
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
